Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduction in Cardiac Mortality With Bivalirudin in Patients With and Without Major Bleeding

Published:2014-01 Issue:1 Volume:63 Page:15-20
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Stone Gregg W.,Clayton Tim,Deliargyris Efthymios N.,Prats Jayne,Mehran Roxana,Pocock Stuart J.

Funder

The Medicines Company

Bristol-Myers Squibb/Sanofi-Aventis

Lilly/Daiichi Sankyo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Bivalirudin during primary PCI in acute myocardial infarction;Stone;N Engl J Med,2008

2. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial;Stone;Lancet,2011

3. Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention;Bertrand;Am J Cardiol,2012

4. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention;Rassen;Eur Heart J,2010

5. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database;Pinto;Circ Cardiovasc Qual Outcomes,2012

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Periprocedural Adverse Events After PCI and CABG on 5-Year Mortality;JACC: Cardiovascular Interventions;2023-02

2. The Evolution of Anticoagulation for Percutaneous Coronary Intervention: A 40-Year Journey;Canadian Journal of Cardiology;2022-10

3. Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy;JAMA Network Open;2022-08-29

4. Primary and Rescue PCI in STEMI;Interventional Cardiology;2022-05-06

5. Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study;Frontiers in Cardiovascular Medicine;2022-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3